Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
The Journal of Clinical Investigation
|
August 4, 2010
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer
Michael A Morse, Amy C Hobeika, Takuya Osada, et al.
Breast Cancer Research : BCR
|
August 11, 2018
Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers
Takuya Osada, Zachary C Hartman, Junping Wei, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 16, 2009
Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines
Gomathinayagam Sinnathamby, Peter Lauer, Jennifer Zerfass, et al.
Cancer Immunology, Immunotherapy : CII
|
April 11, 2012
Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects
Takuya Osada, Peter Berglund, Michael A Morse, et al.
Journal of Translational Medicine
|
February 23, 2005
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
Michael A Morse, Jennifer Garst, Takuya Osada, et al.
Journal of Translational Medicine
|
February 14, 2012
Phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibition [corrected]
Erika Hamilton, Kimberly Blackwell, Amy C Hobeika, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2009
Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine
Takuya Osada, Christopher Y Woo, Matthew McKinney, et al.
Vaccine
|
October 18, 2011
Increasing vaccine potency through exosome antigen targeting
Zachary C Hartman, Junping Wei, Oliver K Glass, et al.
Journal of the National Cancer Institute
|
September 21, 2010
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer
Xinhui Wang, Takuya Osada, Yangyang Wang, et al.
Journal of Immunological Methods
|
December 13, 2005
Maximizing the retention of antigen specific lymphocyte function after cryopreservation
Mary L Disis, Corazon dela Rosa, Vivian Goodell, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
The Journal of Clinical Investigation
|
August 4, 2010
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer
Michael A Morse, Amy C Hobeika, Takuya Osada, et al.
Breast Cancer Research : BCR
|
August 11, 2018
Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers
Takuya Osada, Zachary C Hartman, Junping Wei, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 16, 2009
Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines
Gomathinayagam Sinnathamby, Peter Lauer, Jennifer Zerfass, et al.
Cancer Immunology, Immunotherapy : CII
|
April 11, 2012
Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects
Takuya Osada, Peter Berglund, Michael A Morse, et al.
Journal of Translational Medicine
|
February 23, 2005
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
Michael A Morse, Jennifer Garst, Takuya Osada, et al.
Journal of Translational Medicine
|
February 14, 2012
Phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibition [corrected]
Erika Hamilton, Kimberly Blackwell, Amy C Hobeika, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2009
Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine
Takuya Osada, Christopher Y Woo, Matthew McKinney, et al.
Vaccine
|
October 18, 2011
Increasing vaccine potency through exosome antigen targeting
Zachary C Hartman, Junping Wei, Oliver K Glass, et al.
Journal of the National Cancer Institute
|
September 21, 2010
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer
Xinhui Wang, Takuya Osada, Yangyang Wang, et al.
Journal of Immunological Methods
|
December 13, 2005
Maximizing the retention of antigen specific lymphocyte function after cryopreservation
Mary L Disis, Corazon dela Rosa, Vivian Goodell, et al.
Page
of 8